sp should be 5x imho, page-550

really excited to see how PTX-100 plays out in this initial data. the multiple potential uses for it is really exciting.

pembrolizumab (Merck) was initially approved for melanoma only, with subsequent research its been approved now for lung cancer (incl. 1st line treatment), colorectal ca, head/neck, bladder/kidney, lymphoma and etc...nearly $US15 billion of sales last year....

touch wood the ability to find numerous indications where It can be studied makes it a true company maker.

dont even get me started on the omnicar lol.